EBI3, IL-17 and FOXP3 mRNA expression levels in PBMCs from patients with LC, CHB and CSHB were significantly higher than those in the controls (P<0.01 or P<0.05). The gene discussed is IL17A; the disease is laryngotracheoesophageal cleft.